Gilead Sciences, Inc. (NEO:GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	207,402	165,636	133,307	145,732	115,262	93,056
Market Cap Growth	25.80%	24.25%	-8.53%	26.44%	23.86%	-12.73%
Enterprise Value	227,167	189,331	154,146	169,659	140,545	95,962
PE Ratio	18.36	239.83	17.82	23.45	14.63	593.74
PS Ratio	5.12	4.00	3.72	3.95	3.34	2.96
PB Ratio	6.94	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	16.25	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	15.40	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.67	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.54	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.52	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	17.80	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	16.14%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	5.45%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	6.15%	8.95%	7.35%	7.75%	11.86%	10.29%
Payout Ratio	-	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.